Li Haojie, Zhao Junjie, Sun Jie, Tian Chenyu, Jiang Quan, Ding Chen, Gan Qiangjun, Shu Ping, Wang Xuefei, Qin Jing, Sun Yihong
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Cancer Center, Zhongshan Hospital, Fudan University, Shanghai, China.
Mol Cancer Res. 2021 Sep;19(9):1454-1464. doi: 10.1158/1541-7786.MCR-20-0933. Epub 2021 May 20.
Wnt signaling is believed to be an important contributor to tumor development and has been reported to be modulated by secreted frizzled-related proteins (SFRP). Nevertheless, the role of secreted frizzled-related protein 4 (SFRP4) in tumorigenesis remains controversial. We aim to explore its biological function in gastric cancer. Genomes analysis based on the Gene Expression Omnibus (GEO) dataset was used to find the differential gene expression between different tumor-node-metastasis (TNM) stages of gastric cancer. IHC was used to determine the relationship between SFRP4 expression and clinicopathologic characteristics in patients with gastric cancer. The influence of SFRP4 on tumor progression was evaluated by CCK-8, colony formation, cell apoptosis, and cell cycle , as well as xenograft model . The methylation status of SFRPs was examined in gastric cancer specimens by quantitative methylation analysis. SFRP4 was most upregulated in advanced gastric cancer. High intratumoral SFRP4 expression, which was associated with tumor invasion and metastasis, was also a poor prognostic indicator for patients with gastric cancer. and studies revealed that SFRP4 could promote tumor growth; however, IWR-1 could suppress tumor growth mediated by SFRP4 overexpression. Mechanistic exploration found that SFRP4 was overexpressed by the decrease of promoter methylation and thus could competitively antagonize the inhibitory effect of SFRP1 on Wnt pathway activation and tumor progression in gastric cancer. IMPLICATIONS: In gastric cancer, the expression of SFRP4 was upregulated by decreased methylation. High intratumoral SFRP4 expression could activate the Wnt pathway to promote tumor progression and predict poor survival of patients with gastric cancer.
Wnt信号通路被认为是肿瘤发展的重要促成因素,并且据报道可被分泌型卷曲相关蛋白(SFRP)调节。然而,分泌型卷曲相关蛋白4(SFRP4)在肿瘤发生中的作用仍存在争议。我们旨在探讨其在胃癌中的生物学功能。基于基因表达综合数据库(GEO)数据集进行基因组分析,以发现胃癌不同肿瘤-淋巴结-转移(TNM)分期之间的差异基因表达。采用免疫组化法确定SFRP4表达与胃癌患者临床病理特征之间的关系。通过CCK-8、集落形成、细胞凋亡和细胞周期以及异种移植模型评估SFRP4对肿瘤进展的影响。通过定量甲基化分析检测胃癌标本中SFRP的甲基化状态。SFRP4在晚期胃癌中上调最为明显。肿瘤内SFRP4高表达与肿瘤侵袭和转移相关,也是胃癌患者预后不良的指标。 和 研究表明,SFRP4可促进肿瘤生长;然而,IWR-1可抑制SFRP4过表达介导的肿瘤生长。机制探索发现,SFRP4因启动子甲基化减少而过度表达,从而可竞争性拮抗SFRP1对胃癌中Wnt通路激活和肿瘤进展的抑制作用。结论:在胃癌中,SFRP4的表达因甲基化减少而上调。肿瘤内SFRP4高表达可激活Wnt通路以促进肿瘤进展,并预示胃癌患者生存不良。